Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 789 | 617 | 1,127 | 1,345 | 1,386 |
| Cost of Goods | 330 | 280 | 420 | 1,090 | N/A |
| Gross Profit | 450 | 330 | 700 | 1,640 | 1,386 |
| Operating Expenses | 850 | 810 | 1,040 | 1,240 | 230 |
| Operating Income | -61 | -193 | 87 | -895 | 1,156 |
| Interest Expense | 0 | 0 | 0 | 1 | 0 |
| Other Income | 11 | -7 | 1,083 | 2,086 | -1,116 |
| Pre-tax Income | -50 | -200 | 1,170 | 1,190 | 40 |
| Income Tax | -20 | -70 | 470 | 490 | N/A |
| Net Income Continuous | -38 | -124 | 701 | 709 | 30 |
| Net Income | $-38 | $-124 | $701 | $709 | $30 |
| EPS Basic Total Ops | -0.01 | -0.05 | 0.26 | 0.26 | 0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.05 | 0.26 | 0.26 | 0.01 |
| EPS Diluted Total Ops | -0.01 | -0.05 | 0.25 | 0.26 | 0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.05 | 0.25 | 0.26 | 0.01 |
| EBITDA(a) | $9 | $-133 | $147 | $-895 | $1,156 |